The external pacemakers market size has grown strongly in recent years. It will grow from $1.6 billion in 2025 to $1.7 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to rising incidence of bradycardia, increasing prevalence of acute myocardial infarction, growth in cardiac surgical procedures, expanding emergency medical services infrastructure, increased availability of cardiac critical care units.
The external pacemakers market size is expected to see strong growth in the next few years. It will grow to $2.09 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to rising burden of cardiovascular diseases, growing aging population, increasing demand for temporary cardiac pacing solutions, expansion of advanced cardiac care facilities, improving access to emergency and critical care services. Major trends in the forecast period include increasing use of external pacemakers in emergency cardiac care, rising adoption of temporary cardiac pacing in surgical settings, growing demand for portable and user-friendly external pacemakers, increasing preference for dual chamber external pacemakers, rising focus on rapid cardiac stabilization in acute care.
The growing incidence of cardiovascular diseases are expected to drive the growth of the external pacemaker market going forward. Cardiovascular disease (CVD) is a class of diseases involving the heart or blood vessels. There is a growing incidence of cardiovascular diseases due to several factors such as sedentary lifestyles, poor dietary habits high in processed foods and sugars, increasing rates of obesity, smoking, high blood pressure, and stress. The external pacemakers are used in cardiovascular diseases to regulate abnormal heart rhythms and improve cardiac function. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular disease claimed 919,032 lives in 2023, accounting for approximately one in every three deaths. Therefore, the growing incidence of cardiovascular diseases is expected to propel the growth of the external pacemaker market.
The increasing healthcare expenditure is expected to propel the growth of the external pacemaker market going forward. Healthcare expenditure refers to the total amount of money spent on healthcare goods and services within a specific period, typically on a national or institutional level. Investment in healthcare can support research and development efforts in the field of external pacemaker leading to an advancements in technology, improved access to device, and a more comprehensive approach to individuals health and healthcare systems. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, U.S. healthcare expenditures in 2023 rose by 7.5%, reaching $4.9 trillion, or approximately $14,570 per individual. Therefore, the increasing healthcare expenditure is driving the growth of the external pacemaker market.
Major companies operating in the external pacemaker market are developing innovative products, such as miniaturized pacemakers, to improve battery life and gain a competitive edge in the market. Miniaturized or leadless pacemakers are small electronic devices implanted in the heart to regulate its rhythm. For instance, in May 2023, Medtronic Plc, an Ireland-based medical device company, received Food and Drug Administration approval for Micra AV2 and Micra VR2, the next generation of its industry-leading miniaturized, leadless pacemakers. They provide up to 40% more battery life than previous models, with projected median battery life ranging from nearly 16 to 17 years. These devices feature advanced algorithms for automatic AV synchrony programming and higher tracking capability for active patients. Micra pacemakers minimize complications and improve the patient experience with their small size and lack of leads or surgical pockets.
Major companies operating in the external pacemakers market are ZOLL Medical Corporation, Shree Pacetronix Ltd, Osypka Medical Inc, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Lepu Medical Technology Co Ltd, Biotronik SE & Co KG, LivaNova PLC, MicroPort CRM, Nihon Kohden Corporation, BPL Medical Technologies, Schiller AG, Progetti Medical Equipment Solutions, Instramed Indústria Médico Hospitalar, Corpuls GmbH, Skanray Technologies Ltd, Bexen Cardio, CU Medical Systems Inc, Advanced Instrumentations.
North America was the largest region in the external peacemakers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the external pacemakers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the external pacemakers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the external pacemakers market by increasing the cost of imported electronic components, batteries, and precision control systems used in pacing devices. These impacts are most evident in hospitals and ambulatory surgical centers across regions reliant on international supply chains, particularly asia-pacific and europe. Higher procurement costs have affected pricing and replacement cycles for temporary pacing systems. However, tariffs are also encouraging local manufacturing, supplier diversification, and cost-optimized device designs, supporting long-term supply resilience.
The external pacemakers market research report is one of a series of new reports that provides external pacemakers market statistics, including external pacemakers industry global market size, regional shares, competitors with a external pacemakers market share, detailed external pacemakers market segments, market trends and opportunities, and any further data you may need to thrive in the external pacemakers industry. This external pacemakers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An external pacemaker is a medical device used to temporarily regulate a patient's heart rate and cardiac output by delivering electrical pulses to the heart via electrodes attached to a patch placed on the chest. These devices are commonly employed to stabilize patients or to provide support during surgical procedures.
The main product types of external pacemakers included are single chamber and dual chamber. Single-chamber external pacemakers are devices that utilize one lead to deliver electrical impulses to regulate the heart's rhythm. It is provided for applications such as bradycardia, and acute myocardial infarction. These devices are used by end-users such as hospitals, ambulatory surgical centers, and others.
The external pacemakers market consists of sales of MRI-compatible pacemakers and conventional pacemakers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The external pacemakers market size is expected to see strong growth in the next few years. It will grow to $2.09 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to rising burden of cardiovascular diseases, growing aging population, increasing demand for temporary cardiac pacing solutions, expansion of advanced cardiac care facilities, improving access to emergency and critical care services. Major trends in the forecast period include increasing use of external pacemakers in emergency cardiac care, rising adoption of temporary cardiac pacing in surgical settings, growing demand for portable and user-friendly external pacemakers, increasing preference for dual chamber external pacemakers, rising focus on rapid cardiac stabilization in acute care.
The growing incidence of cardiovascular diseases are expected to drive the growth of the external pacemaker market going forward. Cardiovascular disease (CVD) is a class of diseases involving the heart or blood vessels. There is a growing incidence of cardiovascular diseases due to several factors such as sedentary lifestyles, poor dietary habits high in processed foods and sugars, increasing rates of obesity, smoking, high blood pressure, and stress. The external pacemakers are used in cardiovascular diseases to regulate abnormal heart rhythms and improve cardiac function. For instance, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular disease claimed 919,032 lives in 2023, accounting for approximately one in every three deaths. Therefore, the growing incidence of cardiovascular diseases is expected to propel the growth of the external pacemaker market.
The increasing healthcare expenditure is expected to propel the growth of the external pacemaker market going forward. Healthcare expenditure refers to the total amount of money spent on healthcare goods and services within a specific period, typically on a national or institutional level. Investment in healthcare can support research and development efforts in the field of external pacemaker leading to an advancements in technology, improved access to device, and a more comprehensive approach to individuals health and healthcare systems. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, U.S. healthcare expenditures in 2023 rose by 7.5%, reaching $4.9 trillion, or approximately $14,570 per individual. Therefore, the increasing healthcare expenditure is driving the growth of the external pacemaker market.
Major companies operating in the external pacemaker market are developing innovative products, such as miniaturized pacemakers, to improve battery life and gain a competitive edge in the market. Miniaturized or leadless pacemakers are small electronic devices implanted in the heart to regulate its rhythm. For instance, in May 2023, Medtronic Plc, an Ireland-based medical device company, received Food and Drug Administration approval for Micra AV2 and Micra VR2, the next generation of its industry-leading miniaturized, leadless pacemakers. They provide up to 40% more battery life than previous models, with projected median battery life ranging from nearly 16 to 17 years. These devices feature advanced algorithms for automatic AV synchrony programming and higher tracking capability for active patients. Micra pacemakers minimize complications and improve the patient experience with their small size and lack of leads or surgical pockets.
Major companies operating in the external pacemakers market are ZOLL Medical Corporation, Shree Pacetronix Ltd, Osypka Medical Inc, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Lepu Medical Technology Co Ltd, Biotronik SE & Co KG, LivaNova PLC, MicroPort CRM, Nihon Kohden Corporation, BPL Medical Technologies, Schiller AG, Progetti Medical Equipment Solutions, Instramed Indústria Médico Hospitalar, Corpuls GmbH, Skanray Technologies Ltd, Bexen Cardio, CU Medical Systems Inc, Advanced Instrumentations.
North America was the largest region in the external peacemakers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the external pacemakers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the external pacemakers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the external pacemakers market by increasing the cost of imported electronic components, batteries, and precision control systems used in pacing devices. These impacts are most evident in hospitals and ambulatory surgical centers across regions reliant on international supply chains, particularly asia-pacific and europe. Higher procurement costs have affected pricing and replacement cycles for temporary pacing systems. However, tariffs are also encouraging local manufacturing, supplier diversification, and cost-optimized device designs, supporting long-term supply resilience.
The external pacemakers market research report is one of a series of new reports that provides external pacemakers market statistics, including external pacemakers industry global market size, regional shares, competitors with a external pacemakers market share, detailed external pacemakers market segments, market trends and opportunities, and any further data you may need to thrive in the external pacemakers industry. This external pacemakers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
An external pacemaker is a medical device used to temporarily regulate a patient's heart rate and cardiac output by delivering electrical pulses to the heart via electrodes attached to a patch placed on the chest. These devices are commonly employed to stabilize patients or to provide support during surgical procedures.
The main product types of external pacemakers included are single chamber and dual chamber. Single-chamber external pacemakers are devices that utilize one lead to deliver electrical impulses to regulate the heart's rhythm. It is provided for applications such as bradycardia, and acute myocardial infarction. These devices are used by end-users such as hospitals, ambulatory surgical centers, and others.
The external pacemakers market consists of sales of MRI-compatible pacemakers and conventional pacemakers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. External Pacemakers Market Characteristics
3. External Pacemakers Market Supply Chain Analysis
4. Global External Pacemakers Market Trends and Strategies
5. External Pacemakers Market Analysis of End Use Industries
7. Global External Pacemakers Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global External Pacemakers Total Addressable Market (TAM) Analysis for the Market
9. External Pacemakers Market Segmentation
10. External Pacemakers Market Regional and Country Analysis
11. Asia-Pacific External Pacemakers Market
12. China External Pacemakers Market
13. India External Pacemakers Market
14. Japan External Pacemakers Market
15. Australia External Pacemakers Market
16. Indonesia External Pacemakers Market
17. South Korea External Pacemakers Market
18. Taiwan External Pacemakers Market
19. South East Asia External Pacemakers Market
20. Western Europe External Pacemakers Market
21. UK External Pacemakers Market
22. Germany External Pacemakers Market
23. France External Pacemakers Market
24. Italy External Pacemakers Market
25. Spain External Pacemakers Market
26. Eastern Europe External Pacemakers Market
27. Russia External Pacemakers Market
28. North America External Pacemakers Market
29. USA External Pacemakers Market
30. Canada External Pacemakers Market
31. South America External Pacemakers Market
32. Brazil External Pacemakers Market
33. Middle East External Pacemakers Market
34. Africa External Pacemakers Market
36. External Pacemakers Market Competitive Landscape and Company Profiles
37. External Pacemakers Market Other Major and Innovative Companies
40. External Pacemakers Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
External Pacemakers Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses external pacemakers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for external pacemakers? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The external pacemakers market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Single Chamber; Dual Chamber2) By Application: Bradycardia; Acute Myocardial Infarction
3) By End-user: Hospitals; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Single Chamber Pacemakers: Unipolar External Pacemakers; Bipolar External Pacemakers2) By Dual Chamber Pacemakers: Unipolar Dual Chamber Pacemakers; Bipolar Dual Chamber Pacemakers
Companies Mentioned: ZOLL Medical Corporation; Shree Pacetronix Ltd; Osypka Medical Inc; Medtronic plc; Abbott Laboratories; Boston Scientific Corporation; Lepu Medical Technology Co Ltd; Biotronik SE & Co KG; LivaNova PLC; MicroPort CRM; Nihon Kohden Corporation; BPL Medical Technologies; Schiller AG; Progetti Medical Equipment Solutions; Instramed Indústria Médico Hospitalar; Corpuls GmbH; Skanray Technologies Ltd; Bexen Cardio; CU Medical Systems Inc; Advanced Instrumentations
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this External Pacemakers market report include:- ZOLL Medical Corporation
- Shree Pacetronix Ltd
- Osypka Medical Inc
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- Lepu Medical Technology Co Ltd
- Biotronik SE & Co KG
- LivaNova PLC
- MicroPort CRM
- Nihon Kohden Corporation
- BPL Medical Technologies
- Schiller AG
- Progetti Medical Equipment Solutions
- Instramed Indústria Médico Hospitalar
- Corpuls GmbH
- Skanray Technologies Ltd
- Bexen Cardio
- CU Medical Systems Inc
- Advanced Instrumentations
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.7 Billion |
| Forecasted Market Value ( USD | $ 2.09 Billion |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
